Chennai: Today, leading hospital chain Fortis Healthcare rolled out Sputnik V as a part of a pilot soft launch, the third vaccine approved for India, for the general public at Fortis Hospital Vadapalani. Around 70 number of people got Sputnik V on the day 1 of the rollout and registration for the vaccination can be done through the COWIN and Aarogya Setu applications. The vaccine stock has been directly procured by Fortis, from Dr. Reddy’s Laboratories, as per Government guidelines and has been priced at Rs. 1,145 (as per government guidelines – inclusive of administrative charges).
While Fortis Hospital Vadapalani continues to administer COVISHIELD AND COVAXIN, Sputnik V is also being made available to the public. Recent trials have shown that Sputnik V, has an efficacy of over 90% and will bring down symptomatic Covid-19 cases by over 90%, making it possible for India’s large population to be safe from infection from future virus strains. Fortis Healthcare ramped up its vaccination drive since April 2021 when vaccines were opened to all age groups above 18.
Dr. Sanjay Pandey, Zonal Director, Fortis Hospital Vadapalani, said, “we are happy to see the interest among general public to get themselves vaccinated. This indicates that the misconceptions on COVID vaccines is evading and people are getting confident on vaccine. Fortis is actively working towards ensuring that as many Indians as possible are fully vaccinated. Till date, our unit was only providing COVAXIN and COVISHIELD, however, we are pleased to announce that Fortis Hospital Vadapalani, in collaboration with Dr. Reddy’s Laboratories, providing the third vaccine option, with the dual objective of expanding and scaling up the vaccination drive and lowering the infection risks to future mutations of the virus. We urge all the eligible citizens to get vaccinated to ensure safe India. It is essential.”
As a part of the phase wise pilot project, the two-dose vaccine has been successfully introduced by Fortis Healthcare at Fortis Hospital, Vadapalani.
https://www.firstpost.com/health/russias-sputnik-v-vaccine-has-91-6-efficacy-against-covid-19-says-study-based-on-phase-3-trials-9265281.html
Gurugram, India – October 11, 2023: Samsung announced exciting offers
Bangalore, 10th October 2023: The Nokia G42 5G (16GB+256G
Bengaluru, October 10, 2023 IN-SPACe (Indian National Space Promotion and
New Delhi, October 3, India- Philips India announces an exciting co
 (1)_1713611592.jpg)
Through this exciting initiative, the brand aims to emerge as the go-to purveyor of authentic Chinese in India
New D
Jaipur, 18 April: Students of Jaipur have recently shown their remarkable achievement in the UPSC Civil Services Examination-
· Technopark-based Lifology holds conversation on IER 2024
Thiru
Business / 20-04-2024
MasterChow taps renowned Chef Ranveer Brar as its Brand Ambassador to champion Asli ChineseSports / 20-04-2024
Aditya Mehta Foundation's para cyclists Jyoti Gaderiya & Arshad Shaik achieve top world rankings in the latest Track Para Rankings, bringing pride to India!Business / 18-04-2024
STUDENTS OF JAIPUR'S JAYSHREE PERIWAL HIGH SCHOOL BRING LAURELS TO SCHOOL IN UPSCBusiness / 18-04-2024
India Employment Report pitches for policy to promote jobsBusiness / 18-04-2024
The EMAK Festoon Silent Heroes Awards-24 Concludes at Le Méridien, KochiPelikken © Copyright 2022, All Rights Reserved
